Kyprolis

Swiss trademark · 641224 · Combined mark · In force

Register entry

Registration number
641224
Application number
65454/2012
Status
In force
Type
Combined mark
As registered
Kyprolis ((fig.))
Filed
Dec 28, 2012
Registered
Mar 19, 2013
Published
Mar 19, 2013
Protected until
Dec 28, 2032
Priority
12.07.2012 US
Language of procedure
German
Vienna classes
24.15.01, 24.15.08, 24.15.21, 26.11.02, 26.11.09, 26.11.10, 27.05.01, 27.05.08
Source
Swissreg

Goods and services

Pharmaceuticals

Pharmaceuticals

As filed

Pharmazeutika.

Science, technology and IT

Pharmazeutische Forschung und Entwicklung; medizinische und wissenschaftliche Forschung, nämlich Durchführung klinischer Versuche; medizinische und wissenschaftliche Forschung auf den Gebieten Krebsbehandlung und Onkologie sowie auf den Gebieten der Behandlung von Entzündungen und Autoimmunkrankheiten.

Translated automatically. Only the text as filed is legally binding.

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Dec 18, 2023

    Agent’s address changed

    Representative
    E. Blum & Co. AG, Patent- und Markenanwälte VSP, Vorderberg 11, 8044 Zürich → E. Blum & Co. AG, Hofwiesenstrasse 349, 8050 Zürich

    Published in Swissreg on 18.12.2023

  2. Nov 29, 2022

    Renewed

    Published in Swissreg on 29.11.2022

  3. Mar 19, 2013

    Registered

    Published in Swissreg on 19.03.2013

Parties

Holder

Onyx Pharmaceuticals, Inc.

249 E. Grand Avenue, South San Francisco, CA 94080, US

Agent

E. Blum & Co. AG

Hofwiesenstrasse 349, 8050 Zürich

The register names each party by name and address. A party is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.